Cero Therapeutics Holdings CERO
OTC CERO
$0.01 +0.01 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings (CERO) Price to Book (2024)

Updated

Cero Therapeutics Holdings' Price to Book was 30.02 in Q3 2024, up 183.3% from the prior quarter.

Analysis

Cero Therapeutics Holdings (CERO) Price to Book (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Cero Therapeutics Holdings 638,128.24 -4.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 30.02
Jun 30, 2024 10.60
Mar 31, 2024 0.10
API Access

Cero Therapeutics Holdings Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CERO&period=max&api_key=YOUR_API_KEY